The company is developing a home testing platform. This specific technology makes it possible to detect protein markers at a consumer price-tag with the ease-of-use of a pregnancy test and with clinical lab performance. The system comprises of a small read-out device and disposable tests. The tests rely on antibody-antigen reactions on silicon photonics technology, combined with microfluidics. The technology has architectural similarities to lateral flow immunoassays.The core proposition is home diagnostics, home monitoring and self-testing by consumers, patients and generally untrained users.
This start-up is developing a “menu” for the self-testing market, with the two first products in the realm of infectious diseases. One focusses on the detection of chlamydia and ghonorrea, while the other on the detection of Influenza virus plus Sars-Cov-2. The senior assay developer will lead the development of one of these key assays which will be brought to market. Both products are developed according to IVD and FDA design control methodologies. Hence, the senior assay developer is responsible for the planning and documentation, according to both regulatory standards.
The senior assay developer will work closely and report to the assay lead in order to develop the product from early stage to market entry. He/She will be responsible for leading the specific assay team, co-planning the experiments, analyzing the data, initiating & providing follow-up of sub-tasks and reporting to stakeholders.
• Ph.D. or Master degree in Biochemistry, Cell Biology, Molecular Biology or related scientific discipline with 3+ years of relevant experience.
• 4+ years in immunoassay development for an IVD and/or FDA product.